The Society of Thoracic Radiology will host its 29th annual meeting March 6 to 9, 2011, at the Hyatt Regency Coconut Point resort in Bonita Springs, FL. The program committee, headed by Dr. Gerald F. Abbott, has designed a comprehensive course of value to all physicians with an interest in cardiopulmonary disease.
The Society of Thoracic Radiology will host its 29th annual meeting March 6 to 9, 2011, at the Hyatt Regency Coconut Point resort in Bonita Springs, FL. The program committee, headed by Dr. Gerald F. Abbott, has designed a comprehensive course of value to all physicians with an interest in cardiopulmonary disease.
Several sessions will help imagers understand the rapidly changing area of lung cancer imaging. The Felson lecture, entitled “Radiologic implications of the new IASLC/ATS/ERS lung adenocarcinoma classification,” will be delivered by Dr. William D. Travis, an internationally known pathologist with a unique interest in radiologic-pathologic correlation. The inaugural Gordon Gamsu Memorial Lecture will be delivered by Dr. David P. Naidich on the topic “Subsolid pulmonary nodules: current approach to diagnosis and management.”
Course lectures will cover lung cancer, diffuse lung disease, pulmonary infections, pulmonary vascular imaging, and coronary and cardiac imaging. The Scanlon symposium, one of the highlights of the meeting, will focus on pulmonary MRI. The Scanlon lecturer, Dr. John D. Newell, Jr., will speak on the “Emerging role of MRI in the diagnosis and management of pulmonary disease.” Multiple workshop sessions will permit interaction with faculty, and three self-assessment modules will provide important opportunities for you to maintain certification needs. You may review the entire program at the Society’s web site.
Can Deep Learning Radiomics with bpMRI Bolster Accuracy for Prostate Cancer Prognosis?
January 22nd 2025An emerging deep learning radiomics model based on biparametric MRI (bpMRI) offered a 14 to 17 percent higher AUC range than PI-RADS scoring for predicting the aggressiveness of prostate cancer, according to new research findings.
PET Agent Gets FDA Fast Track Designation for Cardiac AL and ATTR Amyloidosis
January 22nd 2025Previously approved for the detection of neuritic beta amyloid plaque, the PET agent (18F)florbetaben is currently being evaluated in a phase 3 multicenter trial for the diagnosis of cardiac amyloidosis.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.